Europe Noninvasive Ventilation Masks Market is expected to reach US$ 1,076.68 million by 2030

Adults Held Larger Europe Noninvasive Ventilation Masks Market Share in 2022 

According to our new research study on "Europe Noninvasive Ventilation Masks Market Forecast to 2030 – Regional Analysis – by Interfaces, Application, Usage, Size, Material, Product Type and End User," the market is expected to grow from US$ 719.83 million in 2022 to US$ 1,076.68 million by 2030; it is anticipated to record a CAGR of 5.2% from 2022 to 2030. The Europe noninvasive ventilation masks market report emphasizes the trends prevalent in the market, along with drivers and deterrents impacting its growth.

Increasing prevalence of chronic obstructive pulmonary diseases and rising inclination toward home healthcare propel the Europe noninvasive ventilation masks market growth. However, the side effects associated with NIV masks hamper the market growth. Technological advancement is expected to bring new market trends in the coming years.

Growing Inclination Toward Home Healthcare Propels Europe Noninvasive Ventilation Masks Market Growth

The World Health Organization (WHO) defines home-based care as a series of services, including psychosocial, physical, or palliative care activities, provided to people in their homes. A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in greater chances of better, consistent, and timely interaction between patient and doctor owing to the growing prominence of cloud and mobility-driven medical devices. The COVID-19 outbreak crisis has triggered the importance of home healthcare due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. By monitoring a patient’s vitals remotely, healthcare professionals can avoid admissions to healthcare facilities. If the cases can be handled virtually, beds are reserved only for patients requiring critical care, which allows hospital administrations to manage their resources more effectively. NIV masks are used to treat altered control of breathing, non-acute upper airway obstruction, neuromuscular weaking such as spinal muscular atrophy (SMA), and partial upper spinal cord disorder. SMA is one of the most common genetic disorders detected in Germany. According to the study titled “Spinal muscular atrophy: best practice of diagnostic, newborn screening and therapy,” ~1 in 7,000 newborns suffers from SMA in Germany. Patients suffering from these conditions do not need to be admitted to the hospital for long. Companies are focusing on developing personalized home ventilator equipment for the treatment of these and other non-acute respiratory diseases. Thus, the rising inclination toward home healthcare for the treatment of respiratory disorders contributes to the growing Europe noninvasive ventilation masks market size.

Based on interfaces, the Europe noninvasive ventilation masks market is bifurcated into masks and accessories. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. In 2022, the masks segment held a larger share of the market and is expected to record a higher CAGR during 2022–2030.

Europe Noninvasive Ventilation Masks Analysis Based on Segmental Evaluation:

Based on application, the Europe noninvasive ventilation masks market is segmented into respiratory dysfunction, chronic obstructive pulmonary disease, pneumonia, and others. In 2022, the respiratory dysfunction segment held the largest Europe noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.

Based on usage, the Europe noninvasive ventilation masks market is bifurcated into pediatrics and adults. In 2022, the adults segment held a larger market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030. Patients aged 65 years and above tend to have more comorbid chronic diseases and disabilities. These individuals need age-appropriate management to reduce the risk of adverse events during hospitalization. NIV can be used to decrease reintubation rate and ICU mortality in subjects who are at risk of developing post-extubation respiratory failure. The NIV can be used as a preventative measure in ICU patients who have been extubated but are at high risk of developing post-extubation respiratory failure as it shortens the duration of invasive ventilation to prevent extubation failure. In addition, the intubation rates, mortality, and length of stay in the ICU can be reduced significantly by using NIV, which also reduces infective complications such as ventilator-associated pneumonia in adults. Also, the increasing prevalence of respiratory diseases due to pollution and smoking in adults fuels the market growth for the adult segment.

Based on size, the Europe noninvasive ventilation masks market is segmented into large, medium, and small. In 2022, the medium segment held the largest share of the market and is expected to record the highest CAGR during 2022–2030. Large and medium-size masks are used to treat adults. Growing pollution and smoking are responsible for increasing cases of respiratory diseases and lung-related diseases. Thus, the rising prevalence of respiratory diseases such as COPD, ARF, asthma, and hospital-acquired pneumonia in adults fuels the demand for large and medium-size masks. Furthermore, in patients affected by severe acute asthma, the addition of NIV to conventional treatment improves lung function and alleviates the exacerbation faster. In patients suffering from COPD, neuromuscular diseases, and obesity hypoventilation syndrome, noninvasive positive pressure ventilation (NIPPV) results in lower mortality, intubations, hospital admissions, and better quality of life. Also, the increase in cases of neurodegenerative diseases and sleep apnea in adults drives the market growth for the segment

Based on material, the Europe noninvasive ventilation masks market is segmented into silicon, gel, and others. In 2022, the silicon segment held the largest market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.

Based on product type, the Europe noninvasive ventilation masks market is bifurcated into single-use and reusable. In 2022, the reusable segment held a larger market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030. The reusable noninvasive ventilation masks are intended for multipatient use in a hospital and clinic. The masks are used after proper recommended cleaning procedures. The regulatory agency closely monitors the cleaning procedures of the reusable masks. Cleaning, disinfection, and sterilization of the mask need to be done in accordance with ISO 17664. The masks can be thermally disinfected with hot steam at a particular temperature or chemically disinfected with the disinfectants and can be autoclaved for full sterilization to be used again. The reusable masks contain adjustable headgear, dual-wall cushion, transparent frame, quick-release clips, and adjustable forehead support. The reusable masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients. These masks can have a non-vented adapter for the hospital and acute conditions as well as a vented adapter for discharge and long-term non-invasive ventilation that is equipped with an additional pressure measurement port and a rotating sleeve. These types of masks are lightweight, comfortable, and easy to use, and assist in providing therapy that helps patients remain compliant during long-term noninvasive ventilation.

The Europe noninvasive ventilation masks market, by end user, is segmented into hospitals, critical and acute care settings, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest share of the market and is expected to record the highest CAGR during 2022–2030.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com